PDL BioPharma Inc (PDLI) - Medical Equipment - Deals and Alliances Profile

PDL BioPharma Inc (PDLI) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME32141D
  • |
  • Pages: 30
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc (PDLI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

PDL BioPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

PDL BioPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

PDL BioPharma Inc, Medical Equipment, Deal Details 10

Asset Purchase 10

LENSAR Acquires Laser Business Unit of Precision Eye Services 10

PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 11

Venture Financing 13

Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 13

Direct Flow Medical Raises USD 50 Million In Venture Financing 14

LensAR Raises USD8 Million in Venture Financing 15

Kaleo To Raise USD 150 Million In Venture Financing 16

LensAR Raises USD 10 Million In Venture Financing 17

LensAR Raises USD 17.4 Million In Venture Financing 18

LensAR Raises USD 5 Million In Venture Financing 19

LensAR Raises USD 24 Million In Series F Financing Round 20

Private Equity 21

LensAR Completes USD 27 Million In Private Equity Financing 21

PDL BioPharma Enters into Royalty Agreement with Viscogliosi Brothers 22

Equity Offering 23

AxoGen Completes Second Tranche Of Private Placement For USD 19 Million 23

Debt Offering 25

PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 25

Acquisition 26

Alphaeon Acquires LENSAR for USD59 Million 26

PDL BioPharma Inc-Key Competitors 27

PDL BioPharma Inc-Key Employees 28

PDL BioPharma Inc-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30

List of Figures

PDL BioPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

PDL BioPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

PDL BioPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

PDL BioPharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

PDL BioPharma Inc, Medical Equipment, Key Facts, 2017 2

PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

PDL BioPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

PDL BioPharma Inc, Deals By Market, 2012 to YTD 2018 8

PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

LENSAR Acquires Laser Business Unit of Precision Eye Services 10

PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 11

Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 13

Direct Flow Medical Raises USD 50 Million In Venture Financing 14

LensAR Raises USD8 Million in Venture Financing 15

Kaleo To Raise USD 150 Million In Venture Financing 16

LensAR Raises USD 10 Million In Venture Financing 17

LensAR Raises USD 17.4 Million In Venture Financing 18

LensAR Raises USD 5 Million In Venture Financing 19

LensAR Raises USD 24 Million In Series F Financing Round 20

LensAR Completes USD 27 Million In Private Equity Financing 21

PDL BioPharma Enters into Royalty Agreement with Viscogliosi Brothers 22

AxoGen Completes Second Tranche Of Private Placement For USD 19 Million 23

PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 25

Alphaeon Acquires LENSAR for USD59 Million 26

PDL BioPharma Inc, Key Competitors 27

PDL BioPharma Inc, Key Employees 28

PDL BioPharma Inc, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

PDL BioPharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17960
Site License
USD 500 INR 35920
Corporate User License
USD 750 INR 53880

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com